BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16880575)

  • 1. Severe cutaneous adverse drug reaction to leflunomide: a report of five cases.
    Shastri V; Betkerur J; Kushalappa PA; Savita TG; Parthasarathi G
    Indian J Dermatol Venereol Leprol; 2006; 72(4):286-9. PubMed ID: 16880575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lichenoid drug reaction to leflunomide].
    Canonne-Courivaud D; Carpentier O; Dejobert Y; Hachulla E; Delaporte E
    Ann Dermatol Venereol; 2003 Apr; 130(4):435-7. PubMed ID: 12843855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cutaneous adverse drug reaction to leflunomide: a report of two cases.
    Jian X; Guo G; Ruan Y; Lin D; Li X
    Cutan Ocul Toxicol; 2008; 27(1):5-9. PubMed ID: 18330828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
    Hassikou H; El Haouri M; Tabache F; Baaj M; Safi S; Hadri L
    Joint Bone Spine; 2008 Oct; 75(5):597-9. PubMed ID: 18805724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis.
    Soliotis F; Glover M; Jawad AS
    Ann Rheum Dis; 2002 Sep; 61(9):850-1. PubMed ID: 12176818
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide.
    Fischer TW; Bauer HI; Graefe T; Barta U; Elsner P
    Dermatology; 2003; 207(4):386-9. PubMed ID: 14657632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study.
    Kiely PD; Johnson DM
    Rheumatology (Oxford); 2002 Jun; 41(6):631-7. PubMed ID: 12048288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.
    Kamata Y; Nara H; Kamimura T; Haneda K; Iwamoto M; Masuyama J; Okazaki H; Minota S
    Intern Med; 2004 Dec; 43(12):1201-4. PubMed ID: 15645660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide: a review of its use in active rheumatoid arthritis.
    Prakash A; Jarvis B
    Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis].
    Jakob A; Porstmann R; Rompel R
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):324-7. PubMed ID: 16638062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus erythematosus with leflunomide: induction or reactivation?
    Gensburger D; Kawashima M; Marotte H; Kanitakis J; Miossec P
    Ann Rheum Dis; 2005 Jan; 64(1):153-5. PubMed ID: 15608317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports.
    Savage RL; Highton J; Boyd IW; Chapman P
    Intern Med J; 2006 Mar; 36(3):162-9. PubMed ID: 16503951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
    Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Kerr OA; Murray CS; Tidman MJ
    Clin Exp Dermatol; 2004 May; 29(3):319-20. PubMed ID: 15115526
    [No Abstract]   [Full Text] [Related]  

  • 16. An unusual case of DRESS syndrome due to leflunomide.
    Vaish AK; Tripathi AK; Gupta LK; Jain N; Agarwal A; Verma SK
    BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Leflunomide-related severe axonal neuropathy].
    Gabelle A; Antoine JC; Hillaire-Buys D; Coudeyre E; Camu W
    Rev Neurol (Paris); 2005 Nov; 161(11):1106-9. PubMed ID: 16288176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review].
    Molina Molina MI; Pinochet Paiva CM; Quezada Morales JI
    Medwave; 2015 Dec; 15(11):e6350. PubMed ID: 26819061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
    Br J Clin Pharmacol; 2004 Aug; 58(2):201-8. PubMed ID: 15255803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.